A case of Hodgkin’s lymphoma with severely impaired liver function treated successfully with gemcitabine followed by ABVD

Rajshekhar Chakraborty1 Hospitalist Services, Essentia Health, Brainerd, MN, USACorrespondence[email protected]

Shiva Kumar Reddy Mukkamalla2 Department of Internal Medicine, Queens Hospital Center (Affiliated Icahn School of Medicine at Mount Sinai), Jamaica, NY, USA

Garfield Gutzmore2 Department of Internal Medicine, Queens Hospital Center (Affiliated Icahn School of Medicine at Mount Sinai), Jamaica, NY, USA

Hon Cheung Chan2 Department of Internal Medicine, Queens Hospital Center (Affiliated Icahn School of Medicine at Mount Sinai), Jamaica, NY, USA

Pages 93-97 | Published online: 23 Mar 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

KuppersRClonotypic B cells in classic Hodgkin lymphomaBlood2009114183970397119875526
PubMed Web of Science ®Google Scholar
BonadonnaGZucaliRMonfardiniSDe LenaMUslenghiCCombination chemotherapy of hodgkin’s disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer197536125225954209
PubMed Web of Science ®Google Scholar
CanellosGPAndersonJRPropertKJChemotherapy of advanced Hodgkin’s disease with MOPP, ABVD, or MOPP alternating with ABVDN Engl J Med199232721147814841383821
PubMed Web of Science ®Google Scholar
LeeuwenburghILugtenburgEPvan BuurenHRZondervanPEde ManRASevere jaundice, due to vanishing bile duct syndrome, as presenting symptom of Hodgkin’s lymphoma, fully reversible after chemotherapyEur J Gastroenterol Hepatol200820214514718188038
PubMed Web of Science ®Google Scholar
McCarthyJGopalAKSuccessful use of full-dose dexamethasone, high-dose cytarabine, and cisplatin as part of initial therapy in non-hodgkin and Hodgkin lymphoma with severe hepatic dysfunctionClin Lymphoma Myeloma20099216717019406729
PubMedGoogle Scholar
HongFSSmithCLAngusPWCrowleyPHoWKHodgkin lymphoma and fulminant hepatic failureLeuk Lymphoma201051594795120367133
PubMed Web of Science ®Google Scholar
KaplanHSDorfmanRFNelsenTSRosenbergSAStaging laparotomy and splenectomy in Hodgkin’s disease: Analysis of indications and patterns of involvement in 285 consecutive, unselected patientsNatl Cancer Inst Monogr1973362913014744588
PubMedGoogle Scholar
KaplanHSContiguity and progression in Hodgkin’s diseaseCancer Res19713111181118135121687
PubMed Web of Science ®Google Scholar
BouroncleBAOlfJWJrVazquesAGPathogenesis of jaundice in Hodgkin’s diseaseArch Intern Med196211087288314014505
PubMedGoogle Scholar
BirrerMJYoungRCDifferential diagnosis of jaundice in lymphoma patientsSemin Liver Dis1987732692773317863
PubMed Web of Science ®Google Scholar
BagleyCMJrThomasLBJohnsonREChretienPBDeVitaVTJrDiagnosis of liver involvement by lymphoma: Results in 96 consecutive peritoneoscopiesCancer19733148408474267529
PubMed Web of Science ®Google Scholar
HanWSJungESKimYH호지킨림프종에 병발된 간내담관 소멸증후군의 자연관해 [Spontaneous resolution of vanishing bile duct syndrome in hodgkin’s lymphoma]Korean J Hepatol2005112164168 Korean15980675
PubMedGoogle Scholar
Cordoba IturriagagoitiaAInarrairaegui BastarricaMPerez de EquizaEZozaya UrmenetaJMMartinez-PenuelaJMBeloqui PerezRRecuperación ductular en el síndrome de los conductillos biliares evanescent en paciente con linfoma de Hodgkin [Ductal regeneration in vanishing bile duct syndrome in Hodgkin’s lymphoma]Gastroenterol Hepatol2005285275278 Spanish15871809
PubMedGoogle Scholar
SantoroABredenfeldHDevizziLGemcitabine in the treatment of refractory Hodgkin’s disease: Results of a multicenter phase II studyJ Clin Oncol200018132615261910893294
PubMed Web of Science ®Google Scholar
BartlettNLNiedzwieckiDJohnsonJLGemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin’s lymphoma: CALGB 59804Ann Oncol20071861071107917426059
PubMed Web of Science ®Google Scholar
BaetzTBelchACoubanSGemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: A phase II study by the national cancer institute of Canada clinical trials groupAnn Oncol200314121762176714630682
PubMed Web of Science ®Google Scholar
GopalAKPressOWShustovAREfficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: A prospective multi-center phase II study by the Puget Sound oncology consortiumLeuk Lymphoma20105181523152920578815
PubMed Web of Science ®Google Scholar
CzyzARomejko-JarosinskaJKnopinska-PoslusznyWTreatment strategy based on gemcitabine-containing salvage chemotherapy used with the intent to proceed to second stem cell transplantation for patients with Hodgkin lymphoma relapsing after a prior autologous transplantLeuk Lymphoma201354597397823025342
PubMed Web of Science ®Google Scholar
VenookAPEgorinMJRosnerGLPhase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and leukemia group B 9565J Clin Oncol200018142780278710894879
PubMed Web of Science ®Google Scholar
Gemzar, Indianapolis, 1996 (Gemcitabine for injection) intravenous useUSALilly USA LLC
Google Scholar
LadanyiMParsaNZOffitKWachtelMSFilippaDAJhanwarSCClonal cytogenetic abnormalities in hodgkin’s diseaseGenes Chromosomes Cancer1991342942991958594
PubMed Web of Science ®Google Scholar
BarthTFMartin-SuberoJIJoosSGains of 2p involving the REL locus correlate with nuclear c-rel protein accumulation in neoplastic cells of classical hodgkin lymphomaBlood200310193681368612511414
PubMed Web of Science ®Google Scholar
Martin-SuberoJIKlapperWSotnikovaAChromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and reed-sternberg cells of classical hodgkin lymphomaCancer Res20066621103321033817079453
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

A case of Hodgkin’s lymphoma with severely impaired liver function treated successfully with gemcitabine followed by ABVD

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A case of Hodgkin’s lymphoma with severely impaired liver function treated successfully with gemcitabine followed by ABVD

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date